David Arkowitz is CFO & EVP +1 at AMAG PHARMACEUTICALS INC. (AMAG). They have made 15 open-market trades across 4 companies since 2007, most recently 2025-06-30.
CIK 0001296999
12 open-market purchases totalling $443K since 2007, against 3 sales. Across 12 scored buys the stock is down 7.3% at ninety days, and 7.6 points behind the S&P over the same stretch.
12 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 17% | 25% | 17% |
| Avg Move | -11.7% | -0.3% | -7.3% |
| Alpha | -9.1% | -1.3% | -7.6% |
| Scored | 12 | 12 | 12 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IBIO | BUY | 2025-01-10 | 2025-01-13 | $2.72 | $50K | +13.3% | +35.8% | -56.5% |
| MCRB | SELL · 10b5-1 | 2024-02-16 | 2024-02-16 | $1.08 | $4K | +5.6% | -29.8% | -14.4% |
| MCRB | SELL · 10b5-1 | 2023-10-30 | 2023-10-31 | $1.35 | $5K | -32.8% | -31.1% | -17.2% |
| FLXN | SELL | 2021-05-10 | 2021-05-12 | $7.23 | $16K | +11.4% | +23.7% | -28.3% |
| FLXN | SELL | 2021-01-05 | 2021-01-07 | $11.13 | $135K | -5.0% | +4.7% | -33.1% |
| FLXN | SELL · 10b5-1 | 2020-05-07 | 2020-05-11 | $10.88 | $26K | +1.2% | +22.3% | +28.9% |
| FLXN | BUY | 2019-05-31 | 2019-06-03 | $11.05 | $28K | -0.9% | +0.8% | +12.3% |
| FLXN | BUY | 2019-05-13 | 2019-05-15 | $11.99 | $48K | -2.5% | -14.9% | -6.8% |
| FLXN | SELL · 10b5-1 | 2019-05-08 | 2019-05-09 | $10.06 | $23K | +14.9% | +2.0% | -10.7% |
| FLXN | BUY | 2018-11-09 | 2018-11-13 | $16.56 | $66K | -3.7% | -17.7% | -17.4% |
| FLXN | BUY | 2018-08-09 | 2018-08-10 | $23.42 | $94K | -6.6% | -6.3% | -26.6% |
| SBPH | BUY | 2017-08-04 | 2017-08-07 | $12.24 | $31K | +1.2% | +20.4% | +29.0% |
| AMAG | BUY | 2011-05-31 | 2011-06-01 | $13.23 | $20K | -23.6% | -3.6% | -3.6% |
| AMAG | SELL · 10b5-1 | 2011-02-24 | 2011-02-28 | $17.07 | $46K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2010-05-28 | 2010-06-01 | $27.06 | $18K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2009-12-01 | 2009-12-02 | $31.78 | $5K | -23.6% | -3.6% | -3.6% |
| AMAG | SELL | 2009-11-12 | 2009-11-12 | $43.42 | $194K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2009-06-02 | 2009-11-12 | $25.61 | $14K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2008-06-11 | 2008-06-13 | $37.50 | $38K | -23.6% | -3.6% | -3.6% |
| AMAG | BUY | 2007-05-05 | 2008-05-06 | $40.38 | $32K | -23.6% | -3.6% | -3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $6.0M |
Shares reported on the most recent Form 4, priced at the 2025-06-25 close. 2 holdings could not be priced and are excluded from the total.